NYSE:SNN - Smith & Nephew Stock Price, Forecast & News

Smith & Nephew trades on the New York Stock Exchange (NYSE) under the ticker symbol "SNN."

Smith & Nephew announced a -- dividend on Monday, September 23rd. Shareholders of record on Friday, October 4th will be paid a dividend of $0.288 per share on Wednesday, October 30th. This represents a yield of 1.5%. The ex-dividend date is Thursday, October 3rd. View Smith & Nephew's Dividend History.

Smith & Nephew plc (NYSE:SNN) issued its earnings results on Monday, November, 17th. The medical equipment provider reported $0.98 EPS for the quarter, beating the Zacks' consensus estimate of $0.39 by $0.59. View Smith & Nephew's Earnings History.

Smith & Nephew is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for Smith & Nephew.

5 brokers have issued 12-month price targets for Smith & Nephew's stock. Their forecasts range from $6.00 to $6.00. On average, they anticipate Smith & Nephew's share price to reach $6.00 in the next twelve months. This suggests that the stock has a possible downside of 88.1%. View Analyst Price Targets for Smith & Nephew.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Smith & Nephew in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Smith & Nephew.

News articles about SNN stock have been trending very negative recently, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Smith & Nephew earned a news impact score of -3.0 on InfoTrie's scale. They also gave news headlines about the medical equipment provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the next several days. View News Stories for Smith & Nephew.

Smith & Nephew saw a increase in short interest in the month of December. As of December 13th, there was short interest totalling 904,300 shares, an increase of 11.0% from the November 28th total of 814,700 shares. Based on an average daily trading volume, of 721,500 shares, the short-interest ratio is currently 1.3 days. Approximately 0.2% of the company's stock are short sold. View Smith & Nephew's Current Options Chain.

Some companies that are related to Smith & Nephew include Intuitive Surgical (ISRG), Edwards Lifesciences (EW), Zimmer Biomet (ZBH), COLOPLAST A/S/ADR (CLPBY), Align Technology (ALGN), Steris (STE), DEMANT A S/ADR (WILYY), MSA Safety (MSA), Wound Management Technologies (WNDM), Wright Medical Group (WMGI), Avanos Medical (AVNS), Inogen (INGN), Establishment Labs (ESTA), Sientra (SIEN) and RTI Surgical (RTIX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Smith & Nephew investors own include Smith & Nephew (SN), RPM International (RPM), Gilead Sciences (GILD), AbbVie (ABBV), Alibaba Group (BABA), Enterprise Products Partners (EPD), Pfizer (PFE), AT&T (T), Alexion Pharmaceuticals (ALXN) and Broadcom (AVGO).

Smith & Nephew's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Dalton Greiner Hartman Maher & Co. (0.04%), Henry James International Management Inc. (0.04%), Boston Trust Walden Corp (0.02%), Eqis Capital Management Inc. (0.01%), FNY Investment Advisers LLC (0.01%) and Reilly Financial Advisors LLC (0.01%).

SNN stock was sold by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co., Boston Trust Walden Corp, Eqis Capital Management Inc., United Services Automobile Association, Telemus Capital LLC, Reilly Financial Advisors LLC, Henry James International Management Inc. and Janney Montgomery Scott LLC.

SNN stock was purchased by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC, Raymond James Trust N.A., Park National Corp OH, IFP Advisors Inc, Advisor Partners LLC, Harel Insurance Investments & Financial Services Ltd. and Huntington National Bank.

Shares of SNN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of SNN stock can currently be purchased for approximately $50.57.

Smith & Nephew has a market capitalization of $22.12 billion and generates $4.90 billion in revenue each year. The medical equipment provider earns $663 million in net income (profit) each year or $2.02 on an earnings per share basis. Smith & Nephew employs 16,377 workers across the globe.View Additional Information About Smith & Nephew.

The official website for Smith & Nephew is http://www.smith-nephew.com/.

Smith & Nephew's mailing address is 15 ADAM STREET, LONDON X0, WC2N 6LA. The medical equipment provider can be reached via phone at 44-20-7401-7646 or via email at [email protected]